Target intelligence / Profile preview

Tooth–oral biofilm interface

Molecular classification
Other (Biological Interface), Biofilm
01

Overview

The tooth–oral biofilm interface is the dynamic boundary between the tooth's mineralized surface, typically covered by an acquired salivary pellicle, and the complex microbial community known as dental plaque. This interface serves as the critical site for the pathogenesis of dental caries and periodontal diseases, as it mediates the exchange of nutrients, metabolic acids, and minerals between the oral environment and the tooth structure (Marsh, P. D., BMC Oral Health, 2006). Therapeutic interventions at this site focus on modulating the biofilm's composition, inhibiting the metabolic activity of acidogenic bacteria, and shifting the chemical equilibrium toward mineral gain rather than loss (Pitts, N. B., et al., Nature Reviews Disease Primers, 2017). Key pharmacological agents like fluoride interact here by forming fluorapatite, which is more resistant to acid dissolution, while antimicrobials like chlorhexidine disrupt the structural integrity of the biofilm (Buzalaf, M. A. R., et al., Monographs in Oral Science, 2011). The interface is characterized by a gradient of pH and oxygen, which influences the ecological succession of microbial species (Bowden, G. H., & Li, Y. H., Advances in Dental Research, 1997). Understanding the physicochemical and biological properties of this interface is essential for developing effective preventive and restorative dental treatments.

Other names
Dental plaque-enamel interfaceTooth-biofilm junctionPellicle-biofilm interfaceOral biofilm-tooth surface boundary
02

Mechanism of action

Drugs targeting this interface work by inhibiting bacterial adhesion, disrupting the biofilm matrix, neutralizing organic acids, or enhancing the precipitation of fluorapatite to promote remineralization of the tooth surface (Buzalaf et al., 2011).

03

Biological functions

Other (Bacterial Adhesion)Other (Mineral Homeostasis)Other (Biofilm Formation)Other (Metabolic Exchange)
04

Disease associations

InfectionOther (Dental Caries)Other (Gingivitis)Other (Periodontitis)
05

Safety considerations

Dental fluorosisExtrinsic tooth stainingOral microbiome dysbiosisAntimicrobial resistanceTissue irritation
06

Interacting drugs

Sodium fluoride

6 more in the full profile.

07

Biomarkers

Biofilm pHStreptococcus mutans levelsLactic acid concentrationCalcium and phosphate ion levels

Beyond the preview

Go deeper on Tooth–oral biofilm interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tooth–oral biofilm interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call